Can a fundus examination lead to phototoxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fundus Examination and Phototoxicity Risk

Fundus examination alone does not typically cause phototoxicity, but extended or intense light exposure during ophthalmologic procedures can potentially lead to phototoxic damage in certain high-risk patients. 1

Phototoxicity Risk Factors

Certain factors increase the risk of phototoxicity during fundus examination:

  • Photosensitizing medications:

    • Tetracyclines
    • Retinoids
    • Amiodarone
    • Hydrochlorothiazide
    • Furosemide
    • Allopurinol
    • Benzodiazepines 1, 2
  • Pre-existing retinal conditions that may increase susceptibility 1

  • Age-related factors: Decreased production of antioxidants and accumulation of endogenous chromophores after middle age 1

  • Prolonged exposure: Extended examination time increases risk 1

Phototoxic Damage Characteristics

When phototoxicity does occur, it presents with:

  • Yellow-gray sub-retinal lesions visible on fundus examination 2
  • Hyporeflectivity at the outer foveal retina on OCT 3
  • Fragmentation of the inner reflective layers on OCT 3
  • Disruption of photoreceptor outer segment structural lines 3
  • Window defects on fluorescein angiography 2, 3

Prevention Strategies

To minimize phototoxicity risk during fundus examination:

  • Minimize exposure time and number of light flashes 1
  • Use blue-blocking filters that remove at least 94% of blue light (400-500 nm wavelength) 1
  • Consider longer wavelengths (red light rather than green or blue) when possible 1
  • Screen for photosensitizing medications before procedures 1, 2
  • Use newer imaging technologies with faster acquisition times 1
  • Provide appropriate eye protection for both patients and operators 1

Monitoring and Management

  • Monitor for early symptoms during examination:

    • Visual discomfort
    • Temporary scotomas
    • Decreased visual acuity 1
  • Stop the procedure if symptoms develop 1

  • If phototoxicity occurs:

    • Most patients have excellent prognosis with complete visual recovery within a few months 1
    • Persistence of symptoms beyond 3-4 months requires close monitoring 1
    • Development of OCT abnormalities on follow-up warrants further evaluation 1

Diagnostic Approach for Suspected Phototoxicity

For patients with suspected phototoxicity after fundus examination:

  1. OCT examination - primary screening tool for detecting retinal structural changes 1
  2. Visual field testing - recommended if symptoms persist 1
  3. Fundus autofluorescence (FAF) - can reveal early parafoveal damage 4
  4. Multifocal electroretinogram (mfERG) - for objective confirmation of suspected field loss 4

Important Considerations

  • Fundus examination alone is not recommended as a screening tool for retinal toxicity, as photoreceptor damage is detectable with other techniques well before visible changes in the fundus 4
  • Standard fundus examination with appropriate technique and duration poses minimal risk to most patients 1
  • Patient education about monocular vision testing to detect changes is important 1

Remember that while phototoxicity from routine fundus examination is rare, awareness of risk factors and preventive measures is essential for safe practice.

References

Guideline

Phototoxicity Detection and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Incidental retinal phototoxicity associated with ingestion of photosensitizing drugs.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2001

Research

[Optical coherence tomography and macular phototoxicity].

Archivos de la Sociedad Espanola de Oftalmologia, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.